Tsukahara, Katharine
Chang, Xiao
Mentch, Frank
Smith-Whitley, Kim
Bhandari, Anita
Norris, Cindy
Glessner, Joseph T.
Hakonarson, Hakon
Funding for this research was provided by:
National Institutes of Health (T32 HG009495)
The Children’s Hospital of Philadelphia (Institutional Development Fund)
Article History
Received: 30 January 2024
Accepted: 22 August 2024
First Online: 29 August 2024
Competing interests
: KSW is the Chief Medical Officer of the Sickle Cell Reproductive Health Education Directive, and a board member of the Sickle Cell Disease Association of America, both nonprofit organizations. She is a current employee of Pfizer/Global Blood Therapeutics and has received stock and/or stock options in this role. The remaining authors have no conflicts of interest to disclose.